Anne Fleckenstein
About Anne Fleckenstein
Anne Fleckenstein serves as the Director of Intellectual Property Legal Counsel at ElevateBio, where she specializes in drafting IP portfolios for biologic therapeutics and providing legal guidance on licensing and acquisitions. With a strong academic background in biology and law, she has extensive experience in patentability analyses and developing strategies to protect intellectual property in the biotech sector.
Work at ElevateBio
Anne Fleckenstein serves as the Director of Intellectual Property Legal Counsel at ElevateBio, a position she has held since 2022. In this role, she focuses on developing strategies to protect clients' inventions from infringement within the biotech and pharmaceutical sectors. Her expertise includes drafting intellectual property portfolios specifically for biologic therapeutics, which encompasses peptide and cellular therapeutics.
Education and Expertise
Anne Fleckenstein holds a PhD in Cellular and Microbial Biology from The Catholic University of America, where she studied from 1996 to 2005. She also earned a Bachelor of Science in Biology from Villanova University, completing her studies from 1991 to 1995. Additionally, she obtained her Juris Doctor from The George Washington University Law School, studying from 2013 to 2017. Her educational background supports her expertise in drafting IP portfolios and conducting freedom-to-operate and patentability analyses for biotech and pharmaceutical inventions.
Background
Before her current role at ElevateBio, Anne Fleckenstein worked as a Patent Agent at Human Genome Sciences from 2007 to 2012. She also served as a Teaching Assistant and Research Assistant at The Catholic University of America from 1996 to 2005. These positions provided her with valuable experience in the fields of intellectual property and biological sciences.
Intellectual Property Specialization
Anne Fleckenstein specializes in drafting intellectual property portfolios for biologic therapeutics and assists clients in developing contracts for licensing intellectual property. She conducts due diligence for acquisitions and provides analyses on freedom-to-operate and patentability for biotech and pharmaceutical inventions. Her work is essential for clients navigating the complexities of intellectual property in the life sciences sector.